BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş.

AGM Information • Apr 14, 2023

Summary Info	2022 Annual General Assembly Meeting Results
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

General Assembly Invitation

General Assembly Type	Annual
Begining of The Fiscal Period	01.01.2022
Ending Date Of The Fiscal Period	31.12.2022
Decision Date	21.03.2023
General Assembly Date	14.04.2023
General Assembly Time	10:30
Record Date (Deadline For Participation In The General Assembly)	13.04.2023
Country	Turkey
City	İSTANBUL
District	BEYKOZ
Address	Kavacık Mahallesi Ertürk Sokak No:3/1 İç Kapı No:1 Beykoz İSTANBUL

Agenda Items

1 - Opening and election of the Meeting Chairperson, authorizing the Meeting Chairperson to sign the minutes of Meeting,

2 - Reading, discussion, and approval of the Board of Directors' Annual Report for the 2022 operating period,

3 - Reading, discussion, and submitting for approval, of the summary of the Independent Auditor's Report prepared by the Independent Audit Firm for the 2022 operating period,

4 - Reading, discussion, and submitting for approval, of the Financial Statements for the 2022 operating period,

5 - Making a resolution on release of the members of the Board of Directors on an individual basis for their activities and transactions for 2022,

6 - Discussing, and making a resolution on, the proposal of the Board of Directors regarding the profit/loss for 2022,

7 - Informing the General Assembly on related party transactions performed in 2022,

8 - Submission of the changes made in Board of Directors Membership during the year for approval of the General Assembly pursuant to Article 363 of the Turkish Commercial Code,

9 - Election of the members of the Board of Directors and determination of their terms of office and attendance fees payable to members,

10 - Informing the shareholders on payments made as part of "Remuneration Policy" to the members of the Board of Directors and senior executives in accordance with the Corporate Governance Principles,

11 - Submission of the independent audit firm appointed by the Board of Directors for 2023 upon proposal by the Audit Committee, for the approval of the General Assembly,

12 - Informing the General Assembly about the share buy-back transactions initiated by the Board of Directors' resolution dated February 14, 2023 within the framework of the Capital Markets Board's ("CMB") Communiqué No. II-22.1 on Buy-Back Shares and the announcement made on February 14, 2023,

13 - Informing the General Assembly Within the Scope of Principle No. 1.3.6 of the Capital Markets Board's Communiqué No. II-17.1 on Corporate Governance,

14 - Informing the General Assembly about the guarantees, pledges and mortgages given by the Company in favour of third parties in 2022 in accordance with the Capital Markets Board regulations,

15 - Informing the shareholders about the donations and aids made by the Company to foundations and associations for social relief purposes in 2022 and setting an upper limit for donations to be made in 2023 in accordance with the Capital Markets Board regulations,

16 - Authorizing the members of the Board of Directors to perform the transactions specified in Articles 395 and 396 of the Turkish Commercial Code and informing the General Assembly about the transactions carried out within this scope in 2022 in line with the Corporate Governance Principles,

17 - Wishes and adjournment.

Corporate Actions Involved In Agenda

Dividend Payment

General Assembly Results

Was The General Assembly Meeting Executed?	Yes
General Assembly Results	The minutes of the Ordinary General Assembly Meeting and the List of Attendees at the Meeting are attached.

Decisions Regarding Corporate Actions

Dividend Payment	Discussed

General Assembly Result Documents

Appendix: 1	BIOEN-Toplantı Tutanağı -14.04.2023.pdf - Minute
Appendix: 2	14.04.2023 Annual General Assembly Meeting Notes.pdf - Minute
Appendix: 3	BIOEN- Hazır Bulunanlar Listesi 14.04.2023.pdf - List of Attendants

Additional Explanations

In case of a discrepancy between the Turkish and English versions of this public disclosure statement, Turkish version shall prevail.